Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
Filing tables
Filing exhibits
- 10-K Annual report
- 2.7 Agreement and Plan of Merger Between Drugmax, Inc & Familymeds Group, Inc.
- 2.8 First Amendment to Agreement and Plan of Merger
- 10.8 1ST Amendment to Loan and Security Agreement
- 10.9 Second Amendment to Loan and Security Agreement
- 23.1 Consent of Bdo Seidman, LLP
- 23.2 Consent of Deloitte & Touche, LLP
- 31.1 Certification of Principal Executive Officer
- 31.2 Certification of Principal Financial Officer
- 32.1 Certification Pursuant to 18 U.s.c Section 1350
- 32.2 Certification Pursuant to 18 U.s.c. Section 1350
Familymeds similar filings
Filing view
External links
Exhibit 23.2
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statement of DrugMax, Inc. on Form S-8 (No. 333-111127) of our reports dated June 27, 2002, appearing in this Annual Report on Form 10-K of DrugMax, Inc. for the year ended March 31, 2004.
/s/ DELOITTE & TOUCHE LLP
Tampa, Florida
July 13, 2004